Novartis AG
NVS · NYSE
9/29/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $7 | $7 | $11 |
| Short-Term Investments | $0 | $0 | $0 | $2 |
| Receivables | $9 | $9 | $9 | $8 |
| Inventory | $6 | $6 | $6 | $6 |
| Other Curr. Assets | $3 | $3 | $3 | $1 |
| Total Curr. Assets | $28 | $26 | $25 | $30 |
| Property Plant & Equip (Net) | $12 | $12 | $11 | $11 |
| Goodwill | $26 | $26 | $25 | $25 |
| Intangibles | $29 | $29 | $27 | $27 |
| Long-Term Investments | $2 | $2 | $2 | $1 |
| Tax Assets | $6 | $5 | $5 | $4 |
| Other NC Assets | $5 | $4 | $4 | $5 |
| Total NC Assets | $79 | $78 | $75 | $73 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $107 | $104 | $100 | $102 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $4 | $5 |
| Short-Term Debt | $8 | $8 | $8 | $8 |
| Tax Payable | $3 | $3 | $3 | $2 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $16 | $16 | $17 | $10 |
| Total Curr. Liab. | $32 | $32 | $32 | $29 |
| LT Debt | $23 | $22 | $22 | $21 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $2 | $3 | $2 |
| Other NC Liab. | $4 | $4 | $4 | $4 |
| Total NC Liab. | $31 | $31 | $30 | $29 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $63 | $62 | $61 | $58 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $44 | $42 | $40 | $0 |
| AOCI | $0 | -$0 | -$2 | -$3 |
| Other Equity | $0 | $0 | $0 | $47 |
| Total Equity | $44 | $42 | $38 | $44 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $107 | $104 | $100 | $102 |
| Net Debt | $21 | $24 | $22 | $18 |